Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Mar 21, 2023

BUY
$0.66 - $1.18 $660 - $1,180
1,000 New
1,000 $660,000
Q3 2021

Mar 22, 2023

BUY
$1.15 - $1.62 $1,150 - $1,620
1,000 New
1,000 $1.19 Million
Q2 2021

Mar 22, 2023

BUY
$1.31 - $2.14 $1,310 - $2,140
1,000 New
1,000 $1.6 Million
Q1 2021

Mar 22, 2023

BUY
$1.85 - $3.04 $1,850 - $3,040
1,000 New
1,000 $1.97 Million

Others Institutions Holding HOTH

About Hoth Therapeutics, Inc.


  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.11M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.